AstraZeneca Commits $500 Million To French Operations
AstraZeneca Commits $500 Million To French Operations
GALWAY, IRELAND--February 5, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.K. pharmaceutical company AstraZeneca is planning to invest $500 million over five years in its French research and manufacturing operations.
Within this article: Details investment plans for France over five years, financial performance, sale of drug lines
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Skanska's 10 Top-Valued Projects Spurred by Natural Gas, Commuter Rail Dema...
- Fluor to Service $1.87 Billion in Projects Set to Begin Construction in Fou...
- It's a Wrap! Pharma-Bio Industry Set to Complete $2 Billion-Plus in North A...
- Chemical Processing Dominates This Year's Project Kickoffs in Mount Vernon,...
- Skanska's 10 Top-Valued Projects Fueled by Natural-Gas Power, Commuter Rail...